News about our portfolio and insights from the vc world
SNAQ Secures Patent for Food Analysis Innovation
SNAQ, a Serpentine Ventures portfolio company, received a US patent for its technology that converts food images into precise nutritional data. This milestone secures their innovative platform for 20 years.
BOYDSense Chosen to Pitch at European Innovation Council HealthTech Day
BOYDSense, a Serpentine Ventures portfolio company, was selected by the European Innovation Council (EISMEA) to pitch at the HealthTech Investor Day in Paris. This recognition highlights their innovation in diabetes tech.
LOXO Expands to Germany with New Munich Office
LOXO, a Serpentine Ventures portfolio company, has launched LOXO GmbH in Munich, marking its entry into the German market. This expansion supports LOXO’s mission to revolutionize autonomous driving for Europe’s commercial fleets.
heyPatient Featured on SAT.1
heyPatient, a Serpentine Ventures portfolio company, was featured on NextIn Business on SAT.1, showing its potential to save costs with digital automation. heyPatient streamlines healthcare for patients, staff, and the Swiss health system.
Luna Begins Pivotal Trials for Automated Insulin Delivery
Luna, a Serpentine Ventures portfolio company, has started pivotal trials for its automated insulin delivery system, designed for the 90% of people who don't use insulin pumps. This innovation aims to improve glucose control.
Correntics Partners with Deloitte Switzerland for Climate Risk Solutions
Correntics, a Serpentine Ventures portfolio company, teams up with Deloitte to help companies identify and mitigate climate risks. This partnership combines scientific data with regulatory expertise to meet climate disclosure requirements.